Of all the Covid-19 vaccine candidates making their way through the regulatory pipeline, the two from Pfizer/BioNTech and Moderna are some of the most exciting. In addition to having reported efficacies of 90% of more...
In a multi-group collaborative involving the National Emerging Infectious Disease Laboratories (NEIDL), the Center for Regenerative Medicine (CReM), and the Center for Network Systems Biology (CNSB), scientists have...
As the world awaits the imminent arrival of one — or several — COVID-19 vaccines, many people may wonder how important vaccines actually are to safeguarding public health. In this feature, we answer that question by...
An experimental vaccine developed in Europe to prevent infection by Crimean-Congo hemorrhagic fever virus (CCHFV) has protected cynomolgus macaques in a new collaborative study from National Institutes of Health...
Re-starting the global economy for billions of people will depend on successfully overcoming logistical challenges in the ‘last mile’ of a COVID-19 vaccine’s journey to immunisation stations, according to a new report...
Factors related to manufacturing, distribution, public acceptance, and the severity of the pandemic will contribute more to the success of a potential COVID-19 vaccination program than the efficacy of the vaccine...
A report released by the US Government Accountability Office (GAO) says supply chain issues could interfere with a smooth rollout of a COVID-19 vaccine and that the Food and Drug Administration (FDA) should disclose...
Non-neuroinvasive herpes simplex virus variant could be a highly regarded vaccine candidate The worldwide need for an effective herpes simplex virus (HSV) vaccine remains a priority because it is a common infection that...
A JAMA Internal Medicine research letter finds that 18% of recovered COVID-19 patients test positive for SARS-CoV-2, the virus that causes COVID-19, but only 3% (1 of 32) carry replicating virus in their respiratory...
An independent data and safety monitoring board (DSMB) overseeing the Phase 3 trial of the investigational COVID-19 vaccine known as mRNA-1273 reviewed trial data and shared its interim analysis with the trial oversight...